$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How should patients use neratinib (neratinib) correctly according to doctor's instructions?
2026-02-01 22:25:32
Check Details
What is the dosage and dosage of tucatinib? Analysis of standard dosage guidelines
2026-02-01 22:25:32
Check Details
What are the main functions and effects of Apelix? Which types of cancer patients are suitable?
2026-02-01 22:25:32
Check Details
Once selumetinib is taken, does it have to be used for a long time? Effects and risks after discontinuing medication
2026-02-01 22:25:32
Check Details
Which generation of targeted drugs does cabozantinib belong to? Differences from other targeted drugs
2026-02-01 22:25:32
Check Details
What is the duration of resistance to enzalutamide? How should the treatment plan be adjusted after drug resistance?
2026-02-01 22:25:32
Check Details
What is the medical insurance reimbursement price of sorafenib? How much does the patient need to pay out of pocket after being reimbursed by medical insurance?
2026-02-01 22:25:32
Check Details
How much does a box of fostatinib cost? How can patients purchase this drug for their own circumstances?
2026-02-01 22:25:32
Check Details
What is the cure rate for Pitobrutinib? What impact does it have on patients' long-term survival?
2026-02-01 22:25:32
Check Details
Can Lenvatinib be reimbursed by medical insurance? What should I pay attention to during the reimbursement process?
2026-02-01 22:25:32
Check Details
What is the function of Fezonatant? How effective is it in treating patients?
2026-02-01 22:25:32
Check Details
How to eliminate the side effects of Besudil? How to deal with the side effects of taking Besudil?
2026-02-01 22:25:32
Check Details
1
2
...
1411
1412
1413
1414
1415
1416
1417
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
2
FDA Approves First mRNA Flu Vaccine mFLUSIVA
3
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
4
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
5
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
6
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
7
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
8
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor
9
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
10
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
11
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
12
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma